Skip to main content

Table 6 Logit models of likelihood of patient innovation and solution sharing

From: Innovation by patients with rare diseases and chronic needs

 

(1)

(2)

(3)

Non-restricted sample

Restricted sample

 

Patient innovation

Solution sharing

Solution sharing

Disease prevalence

0.15 (0.15)

−0.13 (0.16)

−0.11 (0.20)

Disease burden

0.27** (0.13)

0.12 (0.14)

0.09 (0.19)

Respondent’s Age

0.13 (0.09)

0.25** (0.1)

0.21** (0.11)

Respondent’s Age squared

−0.002* (0.0)

−0.002** (0.0)

−0.002* (0.001)

Disease Duration

0.02 (0.05)

−0.07* (0.04)

−0.13*** (0.05)

Disease Duration squared

−0.001 (0.0)

0.002* (0.0)

0.002*** (0.001)

Gender

−0.51 (0.42)

−0.25 (0.49)

−0.29 (0.55)

Academic Degree

0.68** (0.3)

0.33 (0.27)

0.37 (0.30)

Employment status

−0.05 (0.38)

−0.13 (0.36)

0.41 (0.44)

Marital status

0.66 (0.4)

−0.01 (0.36)

−0.25 (0.45)

Medical patient community membership

0.39 (0.43)

0.29 (0.44)

0.30 (0.51)

Improvement in overall quality of life (before-after solution use)

 

0.52*** (0.11)

0.55*** (0.15)

Constant

−7.26*** (2.2)

−7.58*** (2.4)

−7.53*** (2.54)

Observations

485

231

159

Chi2

28.8

39.1

27.3

McFaden’s pseudo R2

0.08

0.16

0.18

c-statistics

0.72

0.77

0.77

  1. Raw coefficients shown; Robust standard errors in parentheses.
  2. *** p < 0.01, ** p < 0.05, * p < 0.1.